MAR. 2024: NEW STUDIES RELEASED Learn More
THE VALUE OF KIDS FIRST
KIDS COME FIRST IN SCIENTIFIC RESEARCH
Thousands of children are diagnosed with cancer and congenital disorders each year, impacting families emotionally and financially. The Gabriella Miller Kids First Pediatric Research Program (Kids First), funded and administered by the National Institutes of Health (NIH) Common Fund, aims to alleviate some of that hardship by improving how we diagnose, treat, and eventually eliminate these threats. This program is a valuable resource for researchers and is a critical investment in pediatric research.
The Kids First Data Resource Center (Kids First DRC) provides robust genetic and clinical data for pediatric cancer and congenital disorders. Kids First data is accessible to researchers worldwide, free of charge, to help us understand these diseases better.
While this valuable program is funded through 2024, Kids First needs continued support to pursue its essential work well into the future.
DISCOVER A NEW APPROACH TO RESEARCH
Kids First is the leading global contributor of pediatric studies for research
STOP TALKING, START DOING
Gabriella’s Story
The Gabriella Miller Kids First Research Act was enacted in April 2014, less than six months after 10-year-old child cancer research advocate Gabriella Miller died from an inoperable brain tumor.
Her efforts to raise childhood cancer awareness, and its connection to congenital disorders, raised hundreds of thousands of dollars for children’s cancer charities. Through her passionate advocacy, Congress passed the Gabriella Miller Kids First Research Act to direct funding into the NIH Common Fund over ten years to support pediatric research.
Gabriella’s mother, Ellyn Miller, continues her daughter’s work to demand better treatments and cures for kids through the Smashing Walnuts Foundation.
GET THE LATEST KIDS FIRST STUDIES
JOIN OUR ONLINE COMMUNITY
Check out the latest news and updates from the Kids First DRC
Follow @kidsfirstdrc
Email info@kidsfirstdrc.org